CClinicalTrials.gg
CompletedNCT02693600Updated Jun 8, 2017

Comparison Between Hemitrapeziectomy and Total Trapeziectomy With Ligament Reconstruction and Tendon Interposition in Trapeziometacarpal Osteoarthritis II-III Eaton-Littler

An interventional study of Ligamentoplasty with partial trapeziectomy and Ligamentoplasty with total trapeziectomy in Trapeziometacarpal Osteoarthritis, sponsored by Corporacion Parc Tauli. Completed at 1 site in Spain. Open to participants aged 45 Years to 85 Years. Per ClinicalTrials.gov, last updated 2017-06-08.

Sponsored by Corporacion Parc Tauli · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
45 Years to 85 Years
Sex
All
01

Study summary

  1. Introduction:

    Investigators think that surgery with preservation of healthy joints (hemitrapeziectomy) in trapeziometacarpal osteoarthritis without affecting sapho-trapezo-trapezoid joints, is better for scaphoid stability by preventing its collapse and thus preserving the stability of the carpus.

  2. Objectives and Hypothesis:

    Ligamentoplasty with partial trapeziectomy in grades II-III Eaton presents better results in the pollicis-lateral pinch (key pinch) strength than ligamentoplasty with total trapeziectomy.

    Main Objective:

    To demonstrate using the dynamometer that the postoperative key pinch strength higher using ligamentoplasty with partial trapeziectomy in grades II-III Eaton.

    Secondary objectives:

    To measure the collapse of the first column of thumb using calibrated radiographic analysis. Pain (E.V.A Scale). Range of motion (measured with goniometer). Quality of life (DISABILITIES OF THE ARM, SHOULDER AND HAND questionnaire).

  3. Methodology:

It is a single-center randomized trial, parallel-group, in which two types of surgical techniques (TT - TP) will be compared. Patients will be randomized in this two techniques will be followed for one year, in routine clinical practice.

02

Conditions studied

  • Trapeziometacarpal Osteoarthritis

Browse trials for

Keywords

  • Total Trapeziectomy
  • Partial Trapeziectomy
  • Ligamentoplasty
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 34 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Corporacion Parc Tauli is the lead sponsor of 163 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with Osteoarthritis in the trapeziometacarpal joint determined by the classification of Eaton-Littler (stages II-III) with trapeziometacarpal joint pain, loss of function, that were included in surgical waiting list and have accepted under informed consent, including the study.

Exclusion criteria

Exclusion Criteria:

  • Patients with osteoarthritis Eaton-Littler (stage IV).
  • Patients with huge affection of trapezium subchondral cysts and poor quality of trabecular bone.
  • Cognitive impairment.
  • Old fracture with impairment of the same extremity.
  • Rheumatic active illness.
  • Patients who withdraw their informed consent, or in case of impossibility of opinion by clinical status, whose legal guardians or close relatives to withdraw their informed consent to participate in the study.
  • Patients who for any reason not related to the indication needed discontinue study participation or impossible to carry out assessments under more than two follow-up visits.
  • Patients in whom it is considered that participation in the clinical study can be a prejudice, the physician responsible for patient care opinion.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
34 participants (actual)

Study arms

  • Active comparator
    Partial Trapeziectomy (PT)

    Patients with Osteoarthritis of the trapeziometacarpal joint determined by the classification of Eaton-Littler (stages II-III) treated with with ligamentoplasty and partial trapeziectomy.

    Procedure: Ligamentoplasty with partial trapeziectomy

  • Active comparator
    Total Trapeziectomy (TT)

    Patients with Osteoarthritis of the trapeziometacarpal joint determined by the classification of Eaton-Littler (stages II-III) treated with ligamentoplasty and total trapeziectomy.

    Procedure: Ligamentoplasty with total trapeziectomy

Interventions

  • ProcedureLigamentoplasty with partial trapeziectomy
  • ProcedureLigamentoplasty with total trapeziectomy
06

What researchers measure

Primary outcomes

  1. Changes in the pollicis-lateral pinch strength

    In kilograms and measured with dynamometer.

    Time frame: Before, three Months and One year after surgery.

Secondary outcomes

  1. Changes in pain score assessed with E.V.A Scale

    Assessment is performed by E.V.A Scale.

    Time frame: Before, three Months and One year after surgery.

  2. Changes in range of motion

    Opposition, retropulsion and radial abduction were registered.

    Time frame: Before, three Months and One year after surgery.

  3. Changes in Collapse of the first column of thumb using calibrated radiographic analysis

    To measure the collapse of the first column of thumb using calibrated radiographic analysis

    Time frame: Before, three Months and One year after surgery.

  4. Changes in Quality of life assessed with the Disabilities of the arm, shoulder and hand questionnaire (DASH questionnaire)

    Assessment is performed by specific Disabilities of the arm, shoulder and hand questionnaire (DASH questionnaire).

    Time frame: Before, three Months and One year after surgery.

07

Study locations

1 site
  • Hospital Universitario Parc Taulí
    Sabadell, Barcelona 08208, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02693600
Lead sponsor
Corporacion Parc Tauli
Responsible party
Ferran Fillat Gomà (MD, MSc, Corporacion Parc Tauli) — Principal investigator
First posted
Feb 26, 2016
Start date
Sep 2014
Primary completion
Feb 2016
Completion
Mar 2017
Last update
Jun 8, 2017

Study contacts

Ricard Sánchez-Flo, MD
study director · Hospital Universitario Parc Taulí de Sabadell
Ferran Fillat-Gomà, MD
principal investigator · Hospital Universitario Parc Taulí de Sabadell

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion